US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...

“Although not named in this case, all drug manufacturers should be ... adding that the company has not raised list prices for ...

The lawsuits generally make two claims: that insulin prices are unreasonably ... placement for a medicine on the formulary, or list of covered drugs, that they control. If a drug maker doesn ...

For example, two plans of one insurer list four insulins in ... changes in the coverage of these drugs, which becomes an important concern for those who need insulin. There are probably 12 or ...

For drugs like insulin, which require delivery devices ... According to an agency press release, the list of patents that the FTC flagged as potentially improper include those for various inhalers ...

This system also means that insurers end up with different rates for each drug company, so a brand of insulin that has a minimal co-pay under one insurance could cost the full list price under ...

which are negotiated with drug manufacturers and are tied to a drug’s list price. Insulin products with higher list prices result in higher rebates and fees for the PBMs, the complaint alleges.

Doescher: I just want to make sure I get that. Haislmaier: The drug, the list price goes up. Doescher: Yes. The price for my insulin goes up. Haislmaier: And you may be paying more as the patient ...

Their medicines originally had monthly list prices set at hundreds of ... weekly at U.S. pharmacies which can get the drug ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine), meaning that it could be used in place of Sanofi's drug ... typically have list prices 15% to ...

Oracle Health’s next-generation EHR is not just designed to be a scribe or an assistant. But rather a doctor’s best resident, ...